These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9131151)
1. Role of platelet-activating factor in skeletal muscle ischemia-reperfusion injury. Silver D; Dhar A; Slocum M; Adams JG; Shukla S Adv Exp Med Biol; 1996; 416():217-21. PubMed ID: 9131151 [TBL] [Abstract][Full Text] [Related]
2. Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia-reperfusion injury. Adams JG; Dhar A; Shukla SD; Silver D J Vasc Surg; 1995 May; 21(5):742-8; discussion 748-9. PubMed ID: 7769733 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF) receptor antagonism by WEB 2170 improves the survival of ischaemic skeletal muscle. Lepore DA; Knight KR; Stewart AG; Riccio M; Morrison WA Ann Acad Med Singap; 1995 Jul; 24(4 Suppl):63-7. PubMed ID: 8572529 [TBL] [Abstract][Full Text] [Related]
4. The role of platelet-activating factor in musculocutaneous flap reperfusion injury. Stotland MA; Kerrigan CL Plast Reconstr Surg; 1997 Jun; 99(7):1989-99; discussion 2000-1. PubMed ID: 9180723 [TBL] [Abstract][Full Text] [Related]
5. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study. Kecskeméti V; Balogh I J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945 [TBL] [Abstract][Full Text] [Related]
6. Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain. Matsuo Y; Kihara T; Ikeda M; Ninomiya M; Onodera H; Kogure K Brain Res; 1996 Feb; 709(2):296-302. PubMed ID: 8833766 [TBL] [Abstract][Full Text] [Related]
7. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Kubes P; Ibbotson G; Russell J; Wallace JL; Granger DN Am J Physiol; 1990 Aug; 259(2 Pt 1):G300-5. PubMed ID: 2166441 [TBL] [Abstract][Full Text] [Related]
8. Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes. Chávez-Cartaya RE; Metcalfe S; Ramirez-Romero P; Calne R; Jamieson NV Transplantation; 1994 May; 57(10):1440-4. PubMed ID: 8197604 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage. Black SC; Driscoll EM; Lucchesi BR J Cardiovasc Pharmacol; 1992 Dec; 20(6):997-1005. PubMed ID: 1282605 [TBL] [Abstract][Full Text] [Related]
11. Antagonism of neutrophil adherence in the deteriorating stroke model in rabbits. Lindsberg PJ; Sirén AL; Feuerstein GZ; Hallenbeck JM J Neurosurg; 1995 Feb; 82(2):269-77. PubMed ID: 7815156 [TBL] [Abstract][Full Text] [Related]
12. Effect of a specific platelet-activating factor antagonist on cardiovascular and peripheral cellular responses to colonic ischemia and reperfusion in anesthetized ponies. Wilson DV; Stick JA Am J Vet Res; 1993 Mar; 54(3):443-8. PubMed ID: 8498751 [TBL] [Abstract][Full Text] [Related]
13. Glycine preserves function and decreases necrosis in skeletal muscle undergoing ischemia and reperfusion injury. Ascher E; Hanson JN; Cheng W; Hingorani A; Scheinman M Surgery; 2001 Feb; 129(2):231-5. PubMed ID: 11174716 [TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor contributes to postischemic vasospasm. Wang WZ; Guo SZ; Tsai TM; Anderson GL; Miller FN J Surg Res; 2000 Apr; 89(2):139-46. PubMed ID: 10729242 [TBL] [Abstract][Full Text] [Related]
15. Involvement of platelet-activating factor in cell death induced under ischemia/postischemia-like conditions in an immortalized hippocampal cell line. Shi LC; Wang HY; Friedman E J Neurochem; 1998 Mar; 70(3):1035-44. PubMed ID: 9489723 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. Ma XL; Weyrich AS; Krantz S; Lefer AM J Pharmacol Exp Ther; 1992 Mar; 260(3):1229-36. PubMed ID: 1545390 [TBL] [Abstract][Full Text] [Related]
18. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist. Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292 [TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. Alloatti G; Levi R; Malan D; Del Sorbo L; Bosco O; Barberis L; Marcantoni A; Bedendi I; Penna C; Azzolino O; Altruda F; Wymann M; Hirsch E; Montrucchio G Cardiovasc Res; 2003 Nov; 60(2):242-9. PubMed ID: 14613853 [TBL] [Abstract][Full Text] [Related]
20. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. Alloatti G; Penna C; Mariano F; Camussi G Am J Physiol Regul Integr Comp Physiol; 2000 Dec; 279(6):R2156-63. PubMed ID: 11080081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]